Tuesday, 13 October 2026 · Bengaluru · New Delhi · San Francisco
Biotech

NewLimit

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Category
Biotech

What NewLimit does

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

We list NewLimit from public sources and are not affiliated with it. Spotted something wrong? Tell us.

Was this page useful? Be the first to rate it